The Mass Spectrometry and Chromatography in Diagnostics Market Size is valued at USD 732.1 Mn in 2023 and is predicted to reach USD 1,613.6 Bn by the year 2031 at an 10.7% CAGR during the forecast period for 2024-2031.
Mass spectrometry (MS) is a powerful analytical technique widely used in clinical settings to identify and quantify clinically relevant analytes, playing a crucial role in diagnosing diseases through biomarkers. Biomarkers, essential for diagnoses, prognoses, and treatment, are analyzed using MS to provide valuable insights into health conditions. Complementing MS, chromatography is a technique used to separate components of a mixture. This process begins by dissolving the mixture in a mobile phase, which then carries it through a stationary phase. Chromatography serves both as an analytical tool, by feeding its output into a detector for analysis, and as a purification tool, by isolating components of a mixture for use in further experiments or procedures.
Modern technologies such as miniature mass spectrometry equipment have the potential to transform point-of-care (POC) diagnostics. These technologies, which are distinguished by their high sensitivity, specificity, and mobility, allow for the quick and precise identification of illnesses In diagnostics, mass spectrometry and chromatography are key tools for applications such as vitamin and hormone profiling, among others. The market for these technologies is expanding rapidly, driven by their advantages over traditional immunoassays and ongoing technological advancements that continue to enhance their adoption and effectiveness. Continuous innovations in mass spectrometry and chromatography technologies enhance their sensitivity, accuracy, and speed, making them more effective and reliable for diagnostics.
Competitive Landscape
Some of the Major Key Players in the Mass Spectrometry and Chromatography in Diagnostics Market are
- Thermo Fisher Scientific Inc.
- Sciex
- Agilent Technologies
- Shimadzu Corporation
- Perkinelmer
- Jeol
- Jasco Corporation
- Teledyne Flir Llc
- Mks Instruments
- Analytik Jena Gmbh
- Hiden Analytical
- Leco
- Waters Corporation
- Tecan Group Ltd.
- Danaher Corporation
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- PerkinElmer Inc.
- Promega Corporation
- Restek Corporation
- Gerstel GmbH & Co. KG
- Phenomenex Inc. (Danaher Corporation)
- Bruker Corporation
- New England Biolabs
- Hamilton Company
- Avantor, Inc. (VWR International, LLC.)
- Chromsystems Instruments & Chemicals GmbH
Market Segmentation:
The mass spectrometry and chromatography in diagnostics market is segmented based on product type, by application type, by sample type, by testing type. Based on the by-product type, the market is segmented into sample preparation, mass spectrometry, and chromatography. Based on the by application type, the market is segmented into therapeutic drug monitoring, vitamins, hormones, methylmalonic acid, immunosuppressants, and others. Based on the sample type, the market is segmented into blood, urine, serum, plasma, and saliva. Based on the by-testing type, the market is segmented into laboratory-developed tests and commercial assays.
The Mass Spectrometry Segment Is Expected To Have The Highest Growth Rate During The Forecast Period
Based on the product type, the market is segmented into sample preparation, mass spectrometry, and chromatography. Among these, The Mass Spectrometry Segment is Expected to have the highest growth rate during the forecast period. Mass spectrometry provides exceptional sensitivity and accuracy in detecting and quantifying analytes, which is critical for precise diagnostics. Ongoing advancements in mass spectrometry technologies, such as miniaturization and improved detection methods, drive its widespread adoption and market dominance. Mass spectrometry is versatile and can be applied to various diagnostic areas, including biomarker discovery, drug testing, and metabolic profiling, enhancing its market appeal. The need for detailed and comprehensive diagnostic data, which mass spectrometry can deliver, supports its leading position in the market.
The Therapeutic Drug Monitoring (TDM) Segment Dominate the Market
Based on the by application type, the market is segmented into therapeutic drug monitoring, vitamins, hormones, methylmalonic acid, immunosuppressants, and others. Among these, the therapeutic drug monitoring (TDM) segment dominates the market. TDM is crucial for ensuring that drug levels remain within the therapeutic range, optimizing patient treatment, and minimizing adverse effects, which drives significant demand for accurate and reliable diagnostic tools. The growing use of complex biopharmaceuticals and biologics necessitates precise monitoring of drug levels, further boosting the TDM segment.
North America Have the Largest Market Share During Forecast Period
North America has a highly developed healthcare infrastructure, including state-of-the-art diagnostic facilities and widespread adoption of advanced technologies. Significant investments in research and development by key players and institutions in North America drive technological innovations and market growth. The region's high healthcare expenditure supports the acquisition and implementation of advanced diagnostic tools and technologies. Supportive regulatory frameworks and reimbursement policies in North America facilitate the adoption and integration of advanced diagnostic technologies.
Recent Developments:
- In June 2024, Thermo Fisher Scientific Inc., introduced the Thermo ScientificTM StellarTM mass spectrometer (MS), a novel tool that combines high sensitivity, quick throughput, and user-friendliness to enable scientists to accelerate their translational omics research and produce ground-breaking findings more effectively.
- In Nov 2023, Shimadzu Corporation started to supply novel goods to contract development and manufacturing organizations (CDMO) and pharmaceutical businesses, which they can utilize to create production procedures for antibody medicines. For triple quadrupole liquid chromatograph mass spectrometers (LCMS), we have released the LC/MS/MS Method Package for Sugars and Sugar Nucleotides as the initial step.
Mass Spectrometry and Chromatography in Diagnostics Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 732.1 Mn |
|
Revenue Forecast In 2031 |
USD 1,613.6 Mn |
|
Growth Rate CAGR |
CAGR of 10.7% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, Application Type, Sample Type, Testing Type |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
Thermo Fisher Scientific Inc., Sciex, Agilent Technologies, Shimadzu Corporation, Perkinelmer, Jeol, Jasco Corporation, Teledyne Flir Llc, Mks Instruments, Analytik Jena Gmbh, Hiden Analytical, Leco, Waters Corporation, Tecan Group Ltd., Danaher Corporation, Merck Kgaa, Bio-Rad Laboratories, Inc., Perkinelmer Inc., Promega Corporation, Restek Corporation, Gerstel Gmbh & Co. KG, Phenomenex Inc., Bruker Corporation, New England Biolabs, Hamilton Company, Avantor, Inc., Chromsystems Instruments & Chemicals Gmbh, and Others
|
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
